🇪🇺 IXIARO in European Union

EMA authorised IXIARO on 31 March 2009

Marketing authorisation

EMA — authorised 31 March 2009

  • Application: EMEA/H/C/000963
  • Marketing authorisation holder: Valneva Austria GmbH
  • Local brand name: Ixiaro
  • Indication: Ixiaro is indicated for active immunisation against Japanese encephalitis in adults, adolescents, children and infants aged two months and older. Ixiaro should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.
  • Status: approved

Read official source →

IXIARO in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is IXIARO approved in European Union?

Yes. EMA authorised it on 31 March 2009.

Who is the marketing authorisation holder for IXIARO in European Union?

Valneva Austria GmbH holds the EU marketing authorisation.